We use cookies to help provide you with the best possible online experience.
By using this site, you agree that we may store and access cookies on your device. Cookie policy.
Cookie settings.
Functional Cookies
Functional Cookies are enabled by default at all times so that we can save your preferences for cookie settings and ensure site works and delivers best experience.
3rd Party Cookies
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Update on the availability of weight loss drugs
Your GP practice will not be able to prescribe the weightless medication Mounjaro and Wegovy
Wegovy is the brand name for semaglutide, a drug which has been licensed and approved by the National Institute for Health and Care Excellence (NICE) for the management of obesity.
Monjuro is the brand name for tirzepatide, a drug which has been licensed and approved by the National Institute for Health and Care Excellence (NICE) for managing overweight and obesity.
Work is now being carried out with specialists across Kent and Medway to allow appropriate referrals to take place.
Read more about this on the Kent and Medway ICB website
Published: May 14, 2025